Thermal energy storage (TES) has been identified by many researchers as one of the cost-effective solutions for not only storing excess or/wasted energy, but also improving systems’ reliability and thermal efficiency. Among TES, phase change materials (PCMs) are gaining more attention due to their ability to store a reasonably large quantity of heat within small temperature differences. Encapsulation is the cornerstone in expanding the applicability of the PCMs. Microencapsulation is a proven, viable method for containment and retention of PCMs in tiny shells. Currently, there are numerous methods available for synthesis of mPCMs, each of which has its own advantages and limitations. This review aims to discuss, up to date, the different manufacturing approaches to preparing PCM microcapsules (mPCMs). The review also highlights the different potential approaches used for the enhancement of their thermophysical properties, including heat transfer enhancement, supercooling suppression, and shell mechanical strength. This article will help researchers and end users to better understand the current microencapsulation technologies and provide critical guidance for selecting the proper synthesis method and materials based on the required final product specifications.

Microencapsulation of phase change materials (PCMs) remain a suitable option within building materials, as they contribute to the thermal mass and provide an energy buffer, an added benefit. This paper presents a novel method for the rapid fabrication of microencapsulated phase change materials (PCMs) at ambient conditions in a perfluoroalkoxy (PFA) coiled tube ultraviolet (UV) reactor. The objective of this study was to optimize key parameters such as the product yield and quality of the as-prepared microcapsules. Rubitherm^® RT-21™ PCM was microencapsulated within shells of poly-methyl-methacrylate (PMMA) through a suspension emulsion polymerization approach, where the crosslinking of polymers was driven by UV radiations with an appropriate photoinitiator. The characteristics of the resulting PCM microcapsules were found to be affected by the volumetric flow rate of the emulsion inside the coiled tube reactor. Higher volumetric flow rates led to higher PCM contents and higher microencapsulation efficiency, resulting in an average particle size of 6.5 µm. Furthermore, the effect of curing time on the PCM microcapsule properties was investigated. The optimum encapsulation yield, conversion, efficiency and PCM content were observed after 10 min of polymerization time. The thermal analysis indicated that the developed process had an efficiency of 85.8%, and the capsules were characterized with excellent thermal properties. Compared to the conventional thermal microencapsulation processes, the use of a coiled tube UV reactor with an appropriate photoinitiator enables the encapsulation of heat-sensitive PCMs at ambient conditions, and reduces the microencapsulation time dramatically. As a result, this novel microencapsulation approach can lead to a wider scope of PCM encapsulation and enable rapid, continuous and potentially large-scale industrial production of PCM microcapsules with low energy consumption.

Nanotechnology is rapidly reshaping the landscape of modern medicine, offering innovative solutions for the diagnosis, treatment, and prevention of complex diseases. This review presents a comprehensive overview of recent advancements in nanomedicine, emphasizing the integration of nanotechnology across key therapeutic and diagnostic domains. From targeted drug delivery and regenerative medicine to cancer therapy and disease monitoring, nanotechnology is paving the way for more precise, effective, and personalized medical interventions. The article synthesizes current research trends, methodologies, and applications, drawing from a wide range of credible scientific sources. In addition to highlighting the scientific and clinical promise of nanomedicine, the review also addresses the multidisciplinary collaboration required among researchers, clinicians, and technologists to drive progress in this evolving field. Furthermore, it considers the ethical, environmental and regulatory challenges that accompany the widespread implementation of nanotechnological innovations in healthcare. This work underscores the transformative potential of nanomedicine and its vital role in shaping the future of healthcare delivery.

Thermal energy storage offers a viable solution for managing intermediate energy availability challenges. Phase change materials (PCMs) have been extensively studied for their capacity to store thermal energy when available and release it when needed, maintaining a narrow temperature range. However, effective utilization of PCMs requires its proper encapsulation in most applications. In this study, microcapsules containing Rubitherm^®(RT) 21 PCM (Tpeak = 21 °C, ΔH = 140 kJ/kg), which is suitable for buildings, were synthesized using a suspension polymerization technique at different operating temperatures (45–75 °C). Two different water-insoluble thermal initiators were evaluated: 2,2-Azobis (2,4-dimethyl valeronitrile) (Azo-65) and benzoyl peroxide (BPO). The prepared microcapsules were characterized using differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), particle size distribution (PSD), scanning electron microscope (SEM), and optical microscopy (OM). Additionally, the microcapsules were subjected to multiple melting and freezing cycles to assess their thermal reliability and performance stability. DSC results revealed that the microcapsules using BPO exhibited a latent heat of melting comparable to those produced with Azo-65 at an operating temperature of 75 °C. However, the onset crystallization temperature for the BPO-encapsulated PCMs was approximately 2 °C lower than that of the Azo-65-encapsulated PCMs. The greatest latent heat of melting, 107.76 J/g, was exhibited by microcapsules produced at 45 °C, representing a PCM content of 82 wt. %. On the other hand, microcapsules synthesized at 55 °C and 75 °C showed latent heats of 96.02 J/g and 95.66 J/g, respectively. The degree of supercooling for PCM microcapsules was reduced by decreasing the polymerization temperature, with the lowest supercooling observed for microcapsules synthesized at 45 °C. All microcapsules exhibited a monodisperse and narrow PSD of ~10 µm, indicating uniformity in microcapsule size and demonstrating that temperature variations had no significant impact on the particle size distribution. Future research should focus on low-temperature polymerization with extended polymerization times.